Skip to main content
logo
Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.3765
+0.0145 (4.01%)
At close: Oct 15, 2026, 4:00 PM EDT
0.3700
-0.0065 (-1.73%)
After-hours: Oct 15, 2026, 7:30 PM EDT

Heron Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-34.05-20.2-13.58-110.56-182.02-220.68
Depreciation & Amortization
2.132.312.492.92.893.02
Other Amortization
0.850.820.960.340.20.9
Loss (Gain) From Sale of Assets
-0.1--0.030.010.070.82
Asset Writedown & Restructuring Costs
0.420.414.410.620.210.48
Loss (Gain) From Sale of Investments
-0.51-0.74-2.14-1.74-0.740.33
Stock-Based Compensation
11.1910.3412.9632.8542.9846.85
Other Operating Activities
11.3411.34----
Change in Accounts Receivable
-9.64-10.71-18.74-8.09-16.556.35
Change in Inventory
-12.1-31.05-11.0512.46-6.19-6.48
Change in Accounts Payable
-0.5-2.728.470.02-0.583.28
Change in Other Net Operating Assets
19.3612.59-6.2812.412.81-38.23
Operating Cash Flow
-11.61-27.59-22.53-58.79-146.91-203.35
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.53-0.32-1.71-1.55-1.83-3.02
Sale of Property, Plant & Equipment
0.050.10.030.010.230.03
Investment in Securities
2.6816.2320.3919.53-1.7335.72
Investing Cash Flow
2.216.0118.7118-3.3232.73

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-137.25-24.35-148.96
Total Debt Issued
137.25137.25-24.35-148.96
Long-Term Debt Repaid
--150----
Total Debt Repaid
-150-150----
Net Debt Issued (Repaid)
-12.76-12.76-24.35-148.96
Issuance of Common Stock
18.719.320.9430.6676.597.07
Other Financing Activities
-0.19---0.9-1.53-
Financing Cash Flow
13.6114.430.9454.1175.06156.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
4.212.85-2.8813.31-75.18-14.6

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-12.14-27.91-24.24-60.33-148.74-206.38
Free Cash Flow Growth
------
Free Cash Flow Margin
-8.03%-18.02%-16.80%-47.49%-138.14%-239.01%
Free Cash Flow Per Share
-0.07-0.17-0.16-0.44-1.37-2.10
Levered Free Cash Flow
-8.84-28.46-25.82-16.84-75.8-103.97
Unlevered Free Cash Flow
-0.81-23.28-23.01-14.76-74.46-103.37

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
9.426.514.863.062.251.24
Change in Working Capital
-2.87-31.88-27.616.79-10.51-35.08
SEC Filings: 10-K · 10-Q